Connection
Christine Walsh to Piperazines
This is a "connection" page, showing publications Christine Walsh has written about Piperazines.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.561 |
|
|
|
-
Penn CA, Wong MS, Walsh CS. Cost-effectiveness of Maintenance Therapy Based on Molecular Classification Following Treatment of Primary Epithelial Ovarian Cancer in the United States. JAMA Netw Open. 2020 12 01; 3(12):e2028620.
Score: 0.539
-
Taylor-Harding B, Aspuria PJ, Agadjanian H, Cheon DJ, Mizuno T, Greenberg D, Allen JR, Spurka L, Funari V, Spiteri E, Wang Q, Orsulic S, Walsh C, Karlan BY, Wiedemeyer WR. Cyclin E1 and RTK/RAS signaling drive CDK inhibitor resistance via activation of E2F and ETS. Oncotarget. 2015 Jan 20; 6(2):696-714.
Score: 0.022